For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Harriet Mayanja-Kizza explores the clinical and immunological impact of Mycobacterium tuberculosis (MTB) on HIV-1 infection and disease. She illustrates how, unlike other HIV related opportunistic infections, successful treatment of MTB disease may in some patients be associated with some degree of decrease in HIV-1 load. However, this is partial, and not sustained, and does not halt the progress of HIV disease.

Event details of The impact of mycobacterium tuberculosis on HIV-1
Date 14 May 2014
Time 11:00 -12:00
Location Aula - Lutherse kerk

H. Mayanja-Kizza, Mycobacterium Tuberculosis and Human Immuno-Deficiency Virus Type 1 Interaction Pathogenesis and Disease Modulation in Dual Infection.

Supervisors

Prof. J.M.A. Lange
Prof. F.G.J. Cobelens

Co-supervisor

Dr M.L. Joloba (Makerere University College of Health Sciences, Uganda)

Aula - Lutherse kerk

Singel 411
1012 XM Amsterdam

Entrance

This event is open to the public.